Table 1.
Participant characteristics stratified by the presence of hepatic steatosis
| Hepatic Steatosis (n = 43) | No Hepatic Steatosis (n = 82) | P-value | |
|---|---|---|---|
| Female | 24 | 64 | <0.001 |
| Age (yrs) | 15 ± 2 | 15 ± 2 | 0.53 |
| BMI (kg/m2) | 33.8 ± 4.9 | 31 ± 4.5 | 0.002 |
| BMI Z score | 2.2 ± 0.4 | 1.9 ± 0.4 | <0.001 |
| Waist circumference (cm) | 111 ± 12 | 100 ± 13 | <0.001 |
| Body fat percent (%) | 38.9 ± 6.1 | 38 ± 5.9 | 0.43 |
| Hepatic Triglyceride (%F/W) | 13.0 ± 12.5 | 3.0 ± 1.2 | <0.001 |
| HOMA | 6.4 ± 8.0 | 3.6 ± 3.2 | 0.43 |
| HDL-cholesterol (mmol/L) | 1.1 ± 0.3 | 1.2 ± 0.3 | 0.23 |
| Triglycerides (mmol/L) | 1.6 ± 0.7 | 1.1 ± 0.5 | <0.001 |
| AST (U/L) | 26.4 ± 13.7 | 21.7 ± 8.8 | 0.008 |
| ALT (U/L) | 31.8 ± 22.8 | 19.0 ± 13.7 | <0.001 |
| Systolic BP (mmHg) | 116 ± 12 | 114 ± 11 | 0.35 |
| Diastolic BP (mmHg) | 62 ± 8 | 65 ± 8 | 0.08 |
| Metabolic syndrome | 40 % | 12 % | <0.001 |
Data are means ± standard deviation unless otherwise stated. BMI Body mass index, HOMA-IR homeostatic model assessment- insulin resistance, HDL High density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase, BP blood pressure